cmAngio® vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS

AI Verdict

While both cmAngio® and Eko Low Ejection Fraction Tool (ELEFT) leverage FDA-cleared AI for early cardiovascular health insights, they operate on fundamentally different data sources and target distinct conditions. cmAngio® analyzes mammograms to detect Breast Arterial Calcifications, providing insights into cardiovascular risk, whereas ELEFT integrates with digital stethoscopes to identify low ejection fraction, a key indicator of heart failure, during routine physical exams.

Choose cmAngio® if…

Choose cmAngio® if your facility aims to enhance women's cardiovascular risk assessment by leveraging existing mammography exams. This AI software identifies Breast Arterial Calcifications (BAC) on both FFDM and DBT, providing valuable insights into cardiovascular health without additional procedures. It's ideal for integrating opportunistic cardiovascular screening into routine breast imaging workflows.

View cmAngio® →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinicians need a rapid, non-invasive screening solution for low ejection fraction during routine physical examinations. This AI algorithm integrates with Eko digital stethoscopes to provide quick results, making it highly suitable for early heart failure risk identification at the point of care in primary care or cardiology settings.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® Eko Low Ejection Fraction Tool (ELEFT)
Pricing Paid, out-of-pocket Unknown
Deployment Cloud-based, integrates with any DICOM-compliant viewer Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cmAngio®

Tool A emphasizes ease of integration with existing radiology workflows, being compatible with any DICOM-compliant viewer and offering quick installation in less than an hour. While Tool B provides rapid results, it requires integration with specific Eko digital stethoscopes, potentially limiting its universal applicability in diverse clinical settings.

Clinical Value

Tie

Both tools offer significant clinical value by addressing critical cardiovascular health needs with FDA-cleared AI. Tool A leverages existing mammogram data to assess cardiovascular risk without additional procedures, while Tool B provides real-time, non-invasive detection of heart failure indicators during routine physical exams. Both enhance early risk assessment and patient care.

Pricing & Value

cmAngio®

Both tools require direct contact for pricing details, indicating a lack of public transparency. However, Tool A explicitly mentions 'Limited-time offers for no-cost implementation and service may be available,' which could offer a significant initial value proposition. Tool B is noted as part of an 'enterprise solution,' which might imply a higher or more complex bundled cost.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

Both tools are FDA-cleared, HIPAA-compliant, and cloud-based, demonstrating foundational enterprise readiness. However, Tool B explicitly confirms having a Business Associate Agreement (BAA) in the structured facts and is positioned as part of an 'enterprise solution,' indicating a more explicit focus on large-scale deployment and comprehensive compliance.

Innovation

cmAngio®

While both are innovative AI tools, Tool A stands out by repurposing existing mammography data to detect Breast Arterial Calcifications (BAC) for cardiovascular risk assessment, adding significant value without requiring new patient procedures or radiation. This novel application of AI to an established screening method is a particularly efficient and impactful innovation.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Based on web search, Eko Health (Tool B) provides a comprehensive online help center, including user manuals for the ELEFT, and various contact options for support. CureMetrix (Tool A) offers general contact information for support but less specific documentation publicly available for cmAngio.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® Eko Low Ejection Fraction Tool (ELEFT)
Tool Name cmAngiou00ae Eko Low Ejection Fraction Tool (ELEFT)
Company CureMetrix Eko Health
Primary Function AI software for detecting Breast Arterial Calcifications (BAC) on mammograms. AI algorithm to aid in early detection of low ejection fraction during routine physical exams.
Key Data Input Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams ECG and heart sound recordings from Eko digital stethoscopes
Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software designed to detect Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams and is compatible with any DICOM-compliant viewer, allowing for BAC identification and reporting without additional radiation or procedures. ELEFT integrates with FDA-cleared Eko digital stethoscopes to analyze ECG and heart sound recordings, providing results in approximately 15 seconds as part of the SENSORAu2122 Cardiac Early Detection Platform.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties. ELEFT is primarily designed for Cardiology, Family Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.